Eye News and Research

Latest Eye News and Research

Subclinical inflammation predicts macular disease

Levels of high-sensitivity C-reactive protein predict the risk for age-related macular degeneration and diabetic macular edema, show results of two independent studies published in JAMA Ophthalmology.

27 Feb 2013

Global eye health company, Bausch + Lomb, names Robert Bertolini as president and chief financial officer

Bausch + Lomb, the global eye health company, has named Robert Bertolini as president and chief financial officer effective immediately. In this capacity, he will oversee the company's Finance, Information Technology and Global Quality and Operations (GQO) functions. Bertolini, who assumes CFO responsibilities from Brian J. Harris, will report to Bausch + Lomb's chief executive officer, Brent Saunders.

27 Feb 2013

Almost Family reports net service revenues of $87M for fourth quarter

Almost Family, Inc., a leading regional provider of home health nursing and personal care services, announced today its financial results for the three months and full year ended December 31, 2012.

27 Feb 2013

Ampio Pharmaceuticals starts Optina clinical trial

Ampio Pharmaceuticals, Inc. announced oral dosing of the first patient in a 505(b)(2) clinical trial of the investigational drug Optina in diabetic macular edema.

27 Feb 2013

Vision CRC develops retinal camera for detection of blinding eye disease and general health disorders

The most advanced technology for use in real-time detection and assessment of common blinding eye disease and general health disorders will soon be available to the world with stimulus funding provided for development by the Australian Government's CRC Program.

27 Feb 2013

Governors mull Medicaid expansion as White House signals states may reduce payments

With federal budget cuts looming, the nation's governors met in Washington and discussed whether or not to expand Medicaid as part of the Affordable Care Act.

27 Feb 2013

Viewpoints: GOP faces pressure from spending cuts effects on daily life; President needs to lead on Medicare cuts

Cuts this draconian have no place in a tottering economy. But, realistically, the only way to break this standoff is for the cuts to exact their toll on daily life, causing Republicans to face pressure from the public to negotiate an alternative plan with higher revenues in March as part of talks to finance the government for the final six months of the fiscal year.

26 Feb 2013

Viewpoints: Health care 'price gouging;' Health law pushing employers to cut workers' hours; Medicare spending must be tamed

Steven Brill's cover story on the Looking Glass world of healthcare pricing may be the longest article Time Magazine has ever published, but more importantly, it is a fresh sign that the medical-industrial complex should be worried as the deadline for launching Obamacare rolls closer.

26 Feb 2013

Orphan, CU to develop enzyme replacement therapy for CBS-deficient homocystinuria

The University of Colorado (CU) has signed exclusive, worldwide licensing and collaboration agreements with rare-disease research-and-development firm Orphan Technologies Ltd to develop an enzyme replacement therapy for Cystathionine Beta-Synthase (CBS) -deficient homocystinuria, a rare, inherited metabolic disease that is often fatal at a young age.

25 Feb 2013

A good night's sleep can also help promote cardiovascular health

Cutting back on sodium and increasing physical activity are not the only ways to improve heart health - a good night's sleep can also help promote cardiovascular health. One expert at the University of Alabama at Birmingham (UAB) says not getting enough sleep can have harmful heart-health effects.

24 Feb 2013

Clearview announces arrival of Catalys Precision Laser System in Southern CA

Clearview Eye & Laser Medical Center announces the arrival of the world's most sophisticated laser cataract surgery system in Southern CA.

24 Feb 2013

Study finds new mutation in UBIAD1 gene that causes Schnyder corneal dystrophy

Research conducted by Dr. Jayne S. Weiss, Professor and Chair of Ophthalmology at LSU Health Sciences Center New Orleans, and colleagues has discovered a new mutation in a gene that causes Schnyder corneal dystrophy (SCD.)

22 Feb 2013

Memorial Sloan-Kettering scientist wins Breakthrough Prize in Life Sciences

Charles L. Sawyers, Chair of Memorial Sloan-Kettering's Human Oncology and Pathogenesis Program (HOPP), was awarded the Breakthrough Prize in Life Sciences today. The award - established by Art Levinson, Sergey Brin, Anne Wojcicki, Mark Zuckerberg, Priscilla Chan, and Yuri Milner - recognizes "excellence in research aimed at curing intractable diseases and extending human life."

21 Feb 2013

International nonproprietary name “auriclosene” approved by WHO for NovaBay’s NVC-422

NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biotechnology company focused on addressing the large unmet therapeutic needs of the global anti-infective market with first-in-class compounds such as its proprietary Aganocides®, today announced that the World Health Organization (WHO) has approved the international nonproprietary name (INN) “auriclosene” (pronounced awr-rih-CLO-zeen) for the Company’s lead Aganocide® compound NVC-422.

21 Feb 2013

Tips to help reduce dry eyes

Some of the last days of winter can be among the worst for your eyes. Winter may be slowly giving way to spring, but the remaining cold days of the season can cause plenty of trouble for the eyes—trouble that is largely avoidable, says a Vanderbilt Eye Institute ophthalmologist.

21 Feb 2013

Supreme Court gives FTC more power to police hospital mergers

The decision is a win for the federal government as it seeks to monitor the trend toward consolidations around the country.

21 Feb 2013

Simple interventions could reduce delirium and improve patient perceptions about sleep quality

A hospital is not the best place to get a good night's sleep, especially in a noisy intensive care unit. It's a cause for concern because studies have shown that a lack of sleep can cause patients to experience delirium-an altered mental state that may delay their recovery and lead to short and long-term confusion and memory problems.

21 Feb 2013

UCSD molecular biologist to receive Breakthrough Prize in Life Sciences

Napoleone Ferrara, MD, PhD, the molecular biologist credited with helping decipher how tumors grow and now senior deputy director for basic sciences at the University of California, San Diego Moores Cancer Center, was today named one of 11 recipients of the inaugural Breakthrough Prize in Life Sciences, which comes with a $3 million cash award.

21 Feb 2013

Sucampo launches RESCULA Eye Drops in the U.S.

Sucampo Pharmaceuticals, Inc. announced that RESCULA Eye Drops had been launched in the U.S. market.

21 Feb 2013

Growth in opioid use prompts safety concerns

Prescriptions for opioid drugs have increased significantly in Germany over the past decade, a survey of insurance data has found.

20 Feb 2013

Eye News and Research

Latest Eye News and Research

Subclinical inflammation predicts macular disease

Global eye health company, Bausch + Lomb, names Robert Bertolini as president and chief financial officer

Almost Family reports net service revenues of $87M for fourth quarter

Ampio Pharmaceuticals starts Optina clinical trial

Vision CRC develops retinal camera for detection of blinding eye disease and general health disorders

Governors mull Medicaid expansion as White House signals states may reduce payments

Viewpoints: GOP faces pressure from spending cuts effects on daily life; President needs to lead on Medicare cuts

Viewpoints: Health care 'price gouging;' Health law pushing employers to cut workers' hours; Medicare spending must be tamed

Orphan, CU to develop enzyme replacement therapy for CBS-deficient homocystinuria

A good night's sleep can also help promote cardiovascular health

Clearview announces arrival of Catalys Precision Laser System in Southern CA

Study finds new mutation in UBIAD1 gene that causes Schnyder corneal dystrophy

Memorial Sloan-Kettering scientist wins Breakthrough Prize in Life Sciences

International nonproprietary name “auriclosene” approved by WHO for NovaBay’s NVC-422

Tips to help reduce dry eyes

Supreme Court gives FTC more power to police hospital mergers

Simple interventions could reduce delirium and improve patient perceptions about sleep quality

UCSD molecular biologist to receive Breakthrough Prize in Life Sciences

Sucampo launches RESCULA Eye Drops in the U.S.

Growth in opioid use prompts safety concerns

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Eye News and Research

Latest Eye News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in